Abbey Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.30 M
- Company Age 24 Year, 13 Days
- Last Filing with ROC 31 Mar 2024
About Abbey Drugs
Abbey Drugs Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 January 2001 and has a history of 24 years. Its registered office is in Chandigarh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Ashwani Khunger, Sunita Khunger, and Anuja Daga serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233CH2001PTC024174
-
Company No.
024174
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Jan 2001
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Abbey Drugs Private Limited offer?
Abbey Drugs Private Limited offers a wide range of products and services, including Herbal Cough Syrup, Ayurvedic Cough Syrup, Ayurvedic Health Tonic, Herbal Uterine Tonic, Pain Balm & Ointments, Ayurvedic Pain Balm, Nutraceuticals, Nutritional Supplements, Mineral Supplement, Iron Syrup.
Who are the key members and board of directors at Abbey Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashwani Khunger
|
Director | 18-Jan-2001 | Current |
|
Sunita Khunger
|
Director | 30-Mar-2005 | Current |
|
Anuja Daga
|
Additional Director | 25-Sep-2020 | Current |
Financial Performance of Abbey Drugs.
Abbey Drugs Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abbey Drugs?
In 2017, Abbey Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Abbey Drugs?
Unlock and access historical data on people associated with Abbey Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abbey Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abbey Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
